This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tenet Healthcare (THC) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Tenet Healthcare (THC) settling at $156.57, representing a -0.11% change from its previous close.
Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio
by Zacks Equity Research
AMN shows growth potential with its broad services and high demand but faces challenges from industry regulations and strong competition in the staffing space.
Inogen Stock Rises 47% in 6 Months: What's Driving the Rally?
by Zacks Equity Research
INGN shows impressive momentum, driven by strong sales growth, an expanding product portfolio and significant advancements in portable oxygen technology.
Should SPDR S&P 400 Mid Cap Value ETF (MDYV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDYV
Glaukos Stock Soars 59.2% Year to Date: What's Behind the Rally?
by Zacks Equity Research
GKOS stock is being driven by strong product demand, international expansion and pipeline progress, which position it for long-term growth despite supply risks.
Here's Why You Should Add AngioDynamics Stock to Your Portfolio
by Zacks Equity Research
ANGO shows growth potential with its NanoKnife system and expanding U.S. sales but faces challenges from pricing pressure and macroeconomic factors.
Tenet Healthcare and Dollar General have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Tenet Healthcare and Dollar General have been highlighted as Zacks Bull and Bear of the Day.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Bull of the Day: Tenet Healthcare (THC)
by Bryan Hayes
This health care leader has advanced more than 115% this year alone, hitting a series of 52-week highs along the way.
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
by Zacks Equity Research
OPK's growth is fueled by Rayaldee's success and strategic partnerships. However, stiff competition and overdependence on its lead product are concerns.
Can Tenet Healthcare's $910M Divestment in Alabama Cure its Debt Woes?
by Zacks Equity Research
More such divestments can be expected from THC in the coming days, which will likely fuel the company's de-leveraging initiatives.
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
5 Stocks Trading Near 52-Week High With Room to Rise Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like THC, SLVM, DVA, NCLH and IAG are seeing price strength, and the momentum is likely to continue.
Should Schwab U.S. Small-Cap ETF (SCHA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SCHA
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
by Zacks Equity Research
AXDX's Arc system gains FDA clearance, automating blood culture prep for faster microbial ID, improved sepsis outcomes and reduced hospital costs.
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is It Worth Investing in Tenet (THC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Tenet (THC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Tenet (THC) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Tenet (THC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Tenet Healthcare (THC) closed the most recent trading day at $166.20, moving +1.83% from the previous trading session.
3 Hospital Stocks to Buy With Strong Earnings Estimate Revisions
by Nalak Das
The U.S. hospital industry has been flying high in the past year. Three hospital stocks to buy are: HCA, THC, UHS.
Ensign Group Stock Up 19.2% in Six Months: More Growth Ahead?
by Zacks Equity Research
ENSG drives growth with strong segmental performance, cash flows and robust acquisitions, positioning itself as a leader in skilled healthcare services.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Tenet Adds $8B in Market Cap in 2024: Why it's Still a Healthy Buy
by Kaibalya Pravo Dey
Despite being close to its peak, THC remains a compelling buy due to its solid fundamentals, appealing valuation, and upward trend in earnings estimates.
Encompass Health Opens 9th Hospital in SC: More in the Pipeline?
by Zacks Equity Research
This new facility is part of EHC's continued strategy to meet the rising demand for rehabilitative services.